The international phase 3 trial involved 1137 people whose high-risk melanoma had been surgically removed.
This is a companion discussion topic for the original entry at https://www.stuff.co.nz/health/361050309/its-being-called-landmark-cancer-vaccine-and-its-got-scientists-very-excited